Oral cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Simrat Sarai (talk | contribs) No edit summary |
No edit summary |
||
| (15 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oral cancer}} | {{Oral cancer}} | ||
{{CMG}}{{AE}}{{Simrat}} | {{CMG}}; {{AE}} {{SSW}}, {{Simrat}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
A PET scan may be diagnostic of spread of oral cancer. | A [[positron emission tomography]] ([[Positron emission tomography|PET scan]]) may be diagnostic of spread of oral cancer. 18-fluorodeoxyglucose [[positron emission tomography]] ([[FDG-PET]]) scanning is useful to identify the extent of cervical [[Lymph nodes|node]] [[metastasis]]. | ||
==PET scan== | ==PET scan== | ||
A PET scan may be useful for seeing if cancer has spread to the lymph nodes, to determine the originating site of cancer when | * A [[Positron emission tomography|PET scan]] may be useful for seeing if the [[cancer]] has spread to the [[lymph nodes]], to determine the originating site of [[cancer]] when found in the [[lymph nodes]] or for checking the entire body for any spreading of [[cancer]] cells.<ref name="pmid24876922">{{cite journal |vauthors=Tantiwongkosi B, Yu F, Kanard A, Miller FR |title=Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma |journal=World J Radiol |volume=6 |issue=5 |pages=177–91 |date=May 2014 |pmid=24876922 |pmc=4037544 |doi=10.4329/wjr.v6.i5.177 |url=}}</ref> | ||
* [[FDG-PET|18-fluorodeoxyglucose positron emission tomography]] ([[FDG-PET]]) scanning is useful to identify the extent of cervical [[Lymph node|node]] [[metastasis]].<ref name="pmid23620633">{{cite journal |vauthors=Castaldi P, Leccisotti L, Bussu F, Miccichè F, Rufini V |title=Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma |journal=Acta Otorhinolaryngol Ital |volume=33 |issue=1 |pages=1–8 |date=February 2013 |pmid=23620633 |pmc=3631810 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
| Line 15: | Line 16: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 12:52, 11 April 2019
|
Oral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oral cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Oral cancer other imaging findings |
|
Risk calculators and risk factors for Oral cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
A positron emission tomography (PET scan) may be diagnostic of spread of oral cancer. 18-fluorodeoxyglucose positron emission tomography (FDG-PET) scanning is useful to identify the extent of cervical node metastasis.
PET scan
- A PET scan may be useful for seeing if the cancer has spread to the lymph nodes, to determine the originating site of cancer when found in the lymph nodes or for checking the entire body for any spreading of cancer cells.[1]
- 18-fluorodeoxyglucose positron emission tomography (FDG-PET) scanning is useful to identify the extent of cervical node metastasis.[2]
References
- ↑ Tantiwongkosi B, Yu F, Kanard A, Miller FR (May 2014). "Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma". World J Radiol. 6 (5): 177–91. doi:10.4329/wjr.v6.i5.177. PMC 4037544. PMID 24876922.
- ↑ Castaldi P, Leccisotti L, Bussu F, Miccichè F, Rufini V (February 2013). "Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma". Acta Otorhinolaryngol Ital. 33 (1): 1–8. PMC 3631810. PMID 23620633.